Swann Arp Adams

Prof. Dr. Swann Arp Adams

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in American Journal of Public Health
Verified
Journal Article
Closed access
SCSeul Ki Choi
Seul Ki Choi
SASwann Arp Adams
Swann Arp Adams
JEJan M. Eberth
Jan M. Eberth
HBHeather M. Brandt
Heather M. Brandt
DFDaniela B. Friedman
Daniela B. Friedman
JHJames R. Hébert
James R. Hébert
Objectives. We estimated the impact on cancer disparities in US states that have chosen or not chosen to expand Medicaid since passage of the Patient Protection and Affordable Care Act.Methods. Data came from the 2013 Uniform Data System for colorectal and cervical cancer screening rates among patients of federally qualified health centers (FQHCs); the 2012 Behavioral Risk Factor Surveillance System for colorectal, cervical, and breast cancer screening rates; and the US Cancer Statistics (2007–2011) for colorectal, cervical, and breast cancer mortality-to-incidence ratios (MIRs). Dyads of Medicaid expansion decisions with cancer screening rates and MIRs were mapped using ArcMap.Results. States that had not expanded Medicaid as of September 2014 had lower cancer screening rates, especially among FQHC patients. Overall, cancer MIRs were not significantly different by Medicaid expansion status. However, Southeastern states without Medicaid expansion tended to have higher cancer MIRs and lower screening rates.Conclusions. Disparities in cancer screening that already disfavor states with high cancer rates may widen in states that have not chosen to expand Medicaid unless significant efforts are mounted to ensure their residents obtain preventive health care.

3 April 2020 in JMIR Aging
Verified
Journal Article
Open access
SHSue P Heiney
Sue P Heiney
SDSara Donevant
Sara Donevant
SASwann Arp Adams
Swann Arp Adams
PPPearman D Parker
Pearman D Parker
HCHongtu Chen
Hongtu Chen
SLSue Levkoff
Sue Levkoff
Background: Mobile health (mHealth) apps are dramatically changing how patients and providers manage and monitor chronic health conditions, especially in the area of self-monitoring. African Americans have higher mortality rates from heart failure than other racial groups in the United States. Therefore, self-management of heart failure may improve health outcomes for African American patients.Objective: The aim of the present study was to determine the feasibility of using an mHealth app, and explore the outcomes of quality of life, including self-care maintenance, management, and confidence, among African American patients managing their condition after discharge with a diagnosis of heart failure.Methods: Prior to development of the app, we conducted qualitative interviews with 7 African American patients diagnosed with heart failure, 3 African American patients diagnosed with cardiovascular disease, and 6 health care providers (cardiologists, nurse practitioners, and a geriatrician) who worked with heart failure patients. In addition, we asked 6 hospital chaplains to provide positive spiritual messages for the patients, since spirituality is an important coping method for many African Americans. These formative data were then used for creating a prototype of the app, named Healthy Heart. Specifically, the Healthy Heart app incorporated the following evidence-based features to promote self-management: one-way messages, journaling (ie, weight and symptoms), graphical display of data, and customized feedback (ie, clinical decision support) based on daily or weekly weight. The educational messages about heart failure self-management were derived from the teaching materials provided to the patients diagnosed with heart failure, and included information on diet, sleep, stress, and medication adherence. The information was condensed and simplified to be appropriate for text messages and to meet health literacy standards. Other messages were derived from interviews conducted during the formative stage of app development, including interviews with African American chaplains. Usability testing was conducted over a series of meetings between nurses, social workers, and computer engineers. A pilot one-group pretest-posttest design was employed with participants using the mHealth app for 4 weeks. Descriptive statistics were computed for each of the demographic variables, overall and subscales for Health Related Quality of Life Scale 14 (HQOL14) and subscales for the Self-Care of Heart Failure Index (SCHFI) Version 6 using frequencies for categorical measures and means with standard deviations for continuous measures. Baseline and postintervention comparisons were computed using the Fisher exact test for overall health and paired t tests for HQOL14 and SCHFI questionnaire subscales.Results: A total of 12 African American participants (7 men, 5 women; aged 51-69 years) diagnosed with heart failure were recruited for the study. There was no significant increase in quality of life (P=.15), but clinically relevant changes in self-care maintenance, management, and confidence were observed.Conclusions: An mHealth app to assist with the self-management of heart failure is feasible in patients with low literacy, low health literacy, and limited smartphone experience. Based on the clinically relevant changes observed in this feasibility study of the Healthy Heart app, further research should explore effectiveness in this vulnerable population.

30 January 2015 in Journal of Community Health
Verified
Journal Article
Closed access
PDF file
SASwann Arp Adams
Swann Arp Adams
SCSeul Ki Choi
Seul Ki Choi
LKLeepao Khang
Leepao Khang
DCDayna A. Campbell
Dayna A. Campbell
DFDaniela B. Friedman
Daniela B. Friedman
JHJames Hebert
James Hebert

26 October 2009 in Cancer
Verified
Journal Article
Open access
PDF file
SASwann Arp Adams
Swann Arp Adams
ESEmily R. Smith
Emily R. Smith
JHJames Hardin
James Hardin
IPIrene Prabhu‐Das
Irene Prabhu‐Das
JFJeanette Fulton
Jeanette Fulton
JHJames R. Hebert
James R. Hebert
BACKGROUND: In the United States, and particularly in South Carolina, African‐American women suffer disproportionately higher mortality rates from breast cancer than European‐American women. The timeliness of patient adherence to the follow‐up of mammographic abnormalities may influence prognosis and survival. The objective of the current investigation was to examine racial differences in the completion and completion time of a diagnostic workup after the finding of a suspicious breast abnormality.METHODS: Study participants of the Best Chance Network, a statewide service program that provides free mammography screening to economically disadvantaged and medically underserved women, were included in the study. Racial differences in tumor characteristics and adherence to recommended workup were tested using chi‐square tests and t tests. Logistic and Cox regression modeling was used to assess the relation between workup completion and other factors among African‐American women and European‐American women.RESULTS: Completion of the workup was associated with the number of previous procedures and income, and no significant differences were noted by race. The amount of time to completion of the workup was influenced by previous procedures, income, and race. After accounting for completion time, African‐American women were 12% less likely than European‐American women to complete the recommended workup (hazard ratio, 0.88; P = .01).CONCLUSIONS: The results from this study established a racial disparity in the time to completion of a diagnostic workup among Best Chance Network participants. These findings highlight the importance of understanding the factors associated with delays in and adherence to completing the recommended workup when breast abnormalities are detected in mammograms. Cancer 2009. © 2009 American Cancer Society.

1 June 2006 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
SASwann Arp Adams
Swann Arp Adams
CMCharles E. Matthews
Charles E. Matthews
JHJames R. Hebert
James R. Hebert
CPCharity Patterson
Charity Patterson
JCJoan E. Cunningham
Joan E. Cunningham
WZWei Zheng
Wei Zheng
Evidence exists that breast tumors differing by estrogen receptor (ER) and progesterone receptor (PR) status may be phenotypically distinct diseases resulting from dissimilar etiologic processes. Few studies have attempted to examine the association of physical activity with breast cancer subtype. Such research may prove instructive into the biological mechanisms of activity. Consequently, this investigation was designed to assess the relationship between physical activity and hormone receptor-defined breast cancers in a population of Asian women in which the distribution of receptor types differed from traditional Western populations. Participants, ages 25 to 64 years, were recruited into this population-based, case-control study of breast cancer conducted in Shanghai, China from August 1996 to March 1998. Histologically confirmed breast cancer cases with available receptor status information (n = 1001) and age frequency-matched controls (n = 1,556) completed in-person interviews. Polytomous logistic regression was used to model the association between measures of activity with each breast cancer subtype (ER+/PR+, ER−/PR−, ER+/PR−, and ER−/PR+) using the control population as the reference group. Exercise in both adolescence and the last 10 years was associated with a decreased risk of both receptor-positive (ER+/PR+) and receptor-negative (ER−/PR−) breast cancers in both premenopausal and postmenopausal women (odds ratios, 0.44 and 0.51 and 0.43 and 0.21, respectively). Sweating during exercise within the last 10 years was also associated with decreased risk for receptor-positive and receptor-negative breast cancers among postmenopausal women (odds ratios, 0.58 and 0.28, respectively). These findings suggest that physical activity may reduce breast cancer risk through both hormonal and nonhormonal pathways. (Cancer Epidemiol Biomarkers Prev 2006;15(6):1170–8)

27 September 2011 in Cancer
Verified
Journal Article
Open access
PDF file
SASwann Arp Adams
Swann Arp Adams
WBWilliam M. Butler
William M. Butler
JFJeanette Fulton
Jeanette Fulton
SHSue P. Heiney
Sue P. Heiney
EWEdith M. Williams
Edith M. Williams
JHJames R. Hebert
James R. Hebert
BACKGROUND: Although much has been done to examine those factors associated with higher mortality among African American women, there is a paucity of literature that examines disparities among rural African Americans in South Carolina. The purpose of this investigation was to examine the association of race and mortality among breast cancer patients in a large cohort residing in South Carolina for which treatment regimens are standardized for all patients.METHODS: Subjects included 1209 women diagnosed with breast cancer between 2000 and 2002 at a large, local hospital containing a comprehensive breast center. Kaplan‐Meier survival curves were calculated to determine survival rates among African American and European American women, stratified by disease stage or other prognostic characteristics. Adjusting for various characteristics, Cox multivariate survival models were used to estimate the hazard ratio (HR).RESULTS: The 5‐year overall all‐cause mortality survival proportion was ∼78% for African American women and ∼89% for European American women, P < 0.01. In analyses of subpopulations of women with identical disease characteristics, African American women had significantly higher mortality than European American women for the same type of breast cancer disease. In multivariate models, African American women had significantly higher mortality than European American women for both breast cancer‐specific death (HR, 2.41; 95% confidence interval [CI], 1.21‐4.79) and all‐cause mortality (HR, 1.42; 95% CI, 1.06‐1.89).CONCLUSIONS: African American women residing in rural South Carolina had lower survival for breast cancer even after adjustment for disease‐related prognostic characteristics. These findings support health interventions among African American breast cancer patients aimed at tertiary prevention strategies or further down‐staging of disease at diagnosis. Cancer 2011. © 2011 American Cancer Society.